Ilet was Beta Bionics’s largest revenue line in fiscal 2025, bringing in $52.06M of $99.56M (52%).
| Contract with Customer, Sales Channel | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Ilet | $10.17M | $46.62M | $52.06M |
| Single-Use Products | $1.29M | $16.41M | $47.50M |
| Total | $11.46M | $63.03M | $99.56M |
Beta Bionics brought in $99.56M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 58.0% from $63.03M in fiscal 2024. Ilet was the largest at $52.06M (52.3%), ahead of Single-Use Products at $47.50M (47.7%).
Compared with fiscal 2024, Single-Use Products grew 189.5% to $47.50M and Ilet grew 11.7% to $52.06M. From fiscal 2023 to 2025, combined revenue from these revenue lines grew from $11.46M to $99.56M, a compound annual growth rate of 194.7%. Ilet's share of the total fell from 88.7% to 52.3%.
Dme Channel was Beta Bionics’s largest revenue line in fiscal 2025, bringing in $52.06M of $76.51M (68%).
| Contract With Customer Sales Channel | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Dme Channel | $10.17M | $46.62M | $52.06M |
| Pbp Channel | $735.00K | $14.29M | $24.46M |
| Total | $10.90M | $60.91M | $76.51M |
Beta Bionics brought in $76.51M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That is less than the $99.56M it reports by contract with customer, sales channel, so these revenue lines do not cover all of its revenue. Dme Channel was the largest at $52.06M (68.0%), ahead of Pbp Channel at $24.46M (32.0%).
Compared with fiscal 2024, Pbp Channel grew 71.2% to $24.46M and Dme Channel grew 11.7% to $52.06M.
Beta Bionics (BBNX) reports its revenue by contract with customer, sales channel and by contract with customer sales channel. In fiscal 2025, Ilet was its largest revenue line, bringing in $52.06M (52.3% of the total), followed by Single-Use Products at $47.50M (47.7%).
Ilet was Beta Bionics' largest revenue line in fiscal 2025, bringing in $52.06M, or 52.3% of the $99.56M total across its two revenue lines.
Single-Use Products grew faster than Ilet in fiscal 2025, up 189.5% from $16.41M to $47.50M. Ilet grew 11.7% to $52.06M.
Every figure comes from Beta Bionics' annual financial filings, as reported. Each line keeps the name Beta Bionics gives it, and years follow its fiscal calendar.
Beta Bionics' revenue by contract with customer, sales channel goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.